Gabelli Healthcare & WellnessRx Trust Declares First Quarter Distribution of $0.15 Per Share
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) has declared a quarterly cash distribution of $0.15 per share, payable on March 24, 2025, to shareholders of record on March 17, 2025. The current distribution breakdown consists of approximately 1% from net investment income, 4% from net capital gains, and 95% return of capital on a book basis.
The Fund's Board of Trustees reviews potential distributions quarterly, considering net asset value and market conditions. The distribution policy may be modified or terminated at any time. Distributions can be treated as long-term capital gain or qualified dividend income, subject to a maximum 20% federal tax rate for individuals in taxable accounts. U.S. shareholders meeting certain income thresholds will be required to pay an additional 3.8% Medicare surcharge on their net investment income.
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) ha dichiarato una distribuzione di cassa trimestrale di $0.15 per azione, che sarà pagata il 24 marzo 2025, agli azionisti registrati il 17 marzo 2025. La ripartizione attuale della distribuzione consiste approssimativamente in 1% da reddito da investimenti netti, 4% da guadagni di capitale netti e 95% ritorno di capitale su base contabile.
Il Consiglio di Amministrazione del Fondo esamina potenziali distribuzioni su base trimestrale, considerando il valore netto degli attivi e le condizioni di mercato. La politica di distribuzione può essere modificata o terminata in qualsiasi momento. Le distribuzioni possono essere trattate come guadagno di capitale a lungo termine o reddito da dividendi qualificati, soggetti a un'aliquota fiscale federale massima del 20% per gli individui in conti tassabili. Gli azionisti statunitensi che soddisfano determinati requisiti di reddito saranno tenuti a pagare un'ulteriore sovrattassa Medicare del 3.8% sul loro reddito da investimenti netti.
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) ha declarado una distribución de efectivo trimestral de $0.15 por acción, que se pagará el 24 de marzo de 2025, a los accionistas registrados el 17 de marzo de 2025. La distribución actual se desglosa aproximadamente en 1% de ingresos netos de inversión, 4% de ganancias de capital netas y 95% de retorno de capital en base contable.
La Junta de Fideicomisarios del Fondo revisa las distribuciones potenciales trimestralmente, considerando el valor neto de los activos y las condiciones del mercado. La política de distribución puede ser modificada o terminada en cualquier momento. Las distribuciones pueden ser tratadas como ganancias de capital a largo plazo o ingresos por dividendos calificados, sujetos a una tasa impositiva federal máxima del 20% para individuos en cuentas imponibles. Los accionistas estadounidenses que cumplan con ciertos umbrales de ingresos deberán pagar un recargo adicional del 3.8% de Medicare sobre sus ingresos netos de inversión.
가벨리 헬스케어 & 웰니스Rx 트러스트 (NYSE:GRX)는 주당 $0.15의 분기 현금 배당금을 선언했으며, 이는 2025년 3월 24일에 지급되고, 2025년 3월 17일 기준 주주에게 지급됩니다. 현재 배당금 분배는 순투자소득의 약 1%, 순자본이익의 4%, 그리고 95%의 자본 반환으로 구성됩니다.
펀드의 이사회는 순자산 가치와 시장 상황을 고려하여 분기별로 잠재적인 배당금을 검토합니다. 배당금 정책은 언제든지 수정되거나 종료될 수 있습니다. 배당금은 장기 자본 이익 또는 자격 있는 배당 소득으로 처리될 수 있으며, 과세 계좌의 개인에게는 최대 20%의 연방세가 부과됩니다. 특정 소득 기준을 충족하는 미국 주주는 순투자소득에 대해 추가 3.8%의 메디케어 추가세를 납부해야 합니다.
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) a déclaré une distribution de trésorerie trimestrielle de 0,15 $ par action, payable le 24 mars 2025, aux actionnaires enregistrés le 17 mars 2025. La répartition actuelle de la distribution se compose d'environ 1% de revenus d'investissement nets, 4% de gains en capital nets et 95% de retour de capital sur une base comptable.
Le Conseil d'Administration du Fonds examine trimestriellement les distributions potentielles, en tenant compte de la valeur nette des actifs et des conditions du marché. La politique de distribution peut être modifiée ou annulée à tout moment. Les distributions peuvent être considérées comme des gains en capital à long terme ou des revenus de dividendes qualifiés, soumis à un taux d'imposition fédéral maximum de 20% pour les particuliers dans des comptes imposables. Les actionnaires américains répondant à certains seuils de revenu devront payer un supplément Medicare de 3,8% sur leurs revenus d'investissement nets.
Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) hat eine vierteljährliche Barausschüttung von 0,15 $ pro Aktie erklärt, die am 24. März 2025 an die am 17. März 2025 registrierten Aktionäre ausgezahlt wird. Die derzeitige Verteilung setzt sich aus ungefähr 1% aus Nettoanlageerträgen, 4% aus Nettokapitalgewinnen und 95% Rückzahlung des Kapitals auf Buchbasis zusammen.
Der Vorstand des Fonds prüft vierteljährlich potenzielle Ausschüttungen, wobei der Nettowert der Vermögenswerte und die Marktbedingungen berücksichtigt werden. Die Ausschüttungspolitik kann jederzeit geändert oder beendet werden. Ausschüttungen können als langfristiger Kapitalgewinn oder als qualifizierte Dividende behandelt werden, unterliegen jedoch einem maximalen Bundessteuersatz von 20% für Personen in steuerpflichtigen Konten. US-Aktionäre, die bestimmte Einkommensgrenzen überschreiten, müssen auf ihre Nettoanlageerträge einen zusätzlichen Medicare-Zuschlag von 3,8% zahlen.
- Maintains consistent quarterly dividend distribution of $0.15 per share
- 95% of current distribution classified as return of capital, indicating insufficient earnings to cover distributions
- Only 1% of distribution comes from net investment income, showing weak underlying earnings
- 4% of distribution from net capital gains, suggesting portfolio appreciation
Insights
The latest quarterly distribution announcement from Gabelli Healthcare & WellnessRx Trust reveals some concerning patterns that warrant careful investor attention. The $0.15 per share distribution's composition is particularly noteworthy, with a striking 95% classified as return of capital, while only 5% comes from actual earnings (1% from net investment income and 4% from capital gains).
This distribution structure raises several red flags about the Fund's underlying performance. When a fund relies heavily on return of capital for its distributions, it's effectively returning investors' original investment rather than generating new value through successful investment operations. This can mask potential underlying performance issues and may gradually erode the fund's asset base if not balanced by corresponding investment gains.
The minimal contribution from net investment income (just 1%) suggests the Fund is struggling to generate sufficient earnings from its portfolio of healthcare and wellness investments. While healthcare traditionally offers defensive characteristics and steady income potential, this distribution composition indicates the Fund may not be fully capitalizing on these sector attributes.
The tax implications are also significant. While return of capital distributions aren't immediately taxable, they reduce an investor's cost basis, potentially leading to larger capital gains taxes when shares are eventually sold. The small portions of qualified dividend income and capital gains (5% combined) will be taxable at their respective rates, including potential exposure to the 3.8% Medicare surcharge for qualifying investors.
Looking ahead, investors should monitor several key metrics:
- Changes in Net Asset Value (NAV) over time to assess whether the high return of capital component is sustainably maintaining fund value
- Future distribution compositions to identify any shifts toward more earnings-based distributions
- The Fund's ability to generate capital gains in the healthcare sector to support distributions
RYE, N.Y., Feb. 13, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a
The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year.
Each quarter, the Board of Trustees reviews the amount of any potential distribution and the income, realized capital gain, or capital available. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and the current financial market environment. The Fund’s distribution policy is subject to modification or termination by the Board of Trustees at any time, and there can be no guarantee that the policy will continue. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.
All or part of the distribution may be treated as long-term capital gain or qualified dividend income (or a combination of both) for individuals, each subject up to the maximum federal income tax rate for long term capital gains, which is currently
If the Fund does not generate sufficient earnings (dividends and interest income, less expenses, and realized net capital gain) equal to or in excess of the aggregate distributions paid by the Fund in a given year, then the amount distributed in excess of the Fund’s earnings would be deemed a return of capital. Since this would be considered a return of a portion of a shareholder’s original investment, it is generally not taxable and would be treated as a reduction in the shareholder’s cost basis.
Long-term capital gains, qualified dividend income, investment company taxable income, and return of capital, if any, will be allocated on a pro-rata basis to all distributions to common shareholders for the year. Based on the accounting records of the Fund currently available, the current distribution paid to common shareholders in 2025 would include approximately
Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. For more information regarding the Fund’s distribution policy and other information about the Fund, call:
Bethany Uhlein
(914) 921-5546
About The Gabelli Healthcare & WellnessRx Trust
The Gabelli Healthcare & WellnessRx Trust is a diversified, closed-end management investment company with
NYSE: GRX
CUSIP – 36246K103
Investor Relations Contact:
Bethany Uhlein
914.921.5546
buhlein@gabelli.com
FAQ
What is GRX's quarterly dividend amount for Q1 2025?
When is GRX's Q1 2025 dividend payable?
What is the composition of GRX's current distribution?
What tax implications do GRX shareholders face for the 2025 distributions?
